Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Annexon Biosciences Inc.
Description mAb targeting complement component 1 q subcomponent (C1q)
Molecular Target Complement component 1 q subcomponent (C1q)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat ophthalmic disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today